OR WAIT null SECS
Agnes Shanley is senior editor of BioPharm International.
More manufacturers are embracing MAM, which simplifies biopharmaceutical product quality testing, and facilitates the measurement and monitoring of critical quality attributes.
In this interview with Biopharm International, Richard Rogers, principal scientist at Just Biotherapeutics and formerly a member of the Amgen team that developed and proved the concept behind MAM, describes the story behind the method, how it is moving from quality control testing into drug development, and how it is helping to guide new product and software development.
eBook: Outsourcing Resources 2019
When referring to this article, please cite it as A. Shanley, "Using the Multiple Attribute Method for Process Development and Quality Control," BioPharm International's Outsourcing Resources eBook (April 2019).